EFFECTS OF ENALAPRIL ON THORACIC AND ABDOMINAL AORTA REMODELING IN EXPERIMENTAL MODELS OF DIFFERENT VARIANTS OF CHRONIC STRESS

Open Access Open Access
Restricted Access Subscription Access

Abstract


Objective: To study the effect of Enalapril on structural changes in the extracellular matrix of the media of the thoracic and abdominal segments of rat aorta under conditions that model different variants of chronic stress. Materials and methods: Wistar rats were used in experiments. Chronic adrenergic or cholinergic stresses were modeled by intraperitoneal administrations of adrenaline or Proserpine, respectively, during two weeks. The effects of Enalapril on modeled stresses were assessed by determination of the volume density of the extracellular space and collagen and elastin fibers of the media of the thoracic and abdominal segments of aorta. Results: The effects of Enalapril on extracellular matrix remodeling were most expressed in the thoracic aorta where the drug, upon the chronic adrenergic stress, prevented fibrosis and decreased collagen degradation and, upon the chronic cholinergic stress, decreased extracellular space remodeling and inhibited progression of fibrosis, in spite of a decrease in the density of elastin. In the abdominal aorta, elastin degradation increased under the effects of either, Enalapril and both variants of chronic stress. Upon chronic cholinergic stress, progressing changes in elastin network were associated with progressing fibrosis. Conclusion: Enalapryl is protective against extracellular matrix remodeling differently, depending on the conditions of stress and on the segment of aorta. Enalapryl effects were most pronounced in the thoracic segment of Wistar rat aorta upon chronic adrenergic stress and less pronounced upon chronic cholinergic stress. No protective effects of Enalapril were found in the abdominal segment of aorta upon any of stress variants.

V R Veber

Novgorod State University

M P Rubanova

Novgorod State University

S V Zhmailova

Novgorod State University

Email: zhmailova.svetlana@yandex.ru

P M Gubskaya

Novgorod State University

L G Proshina

Novgorod State University

V E Karev

SRI of childhood infections

Email: vadimkarev@yandex.ru

Y Y Rumyantsev

Novgorod State University

I A Ataev

Novgorod State University

N A Kulik

Novgorod State University

  1. Braunwald E., Domanski M. J., Fowler S. E., Geller N. L., Gersh B. J., Hsia J., Pfeffer M. A., Rice M. M., Rosenberg Y. D., Rouleau J. L. Angiotensin-converting-enzyme inhibition in stable coronary artery disease // N. Engl. J. Med.- 2004.- Vol. 351.- Р. 2058.
  2. Дикур О. Н., Драпкина О. Н. Возможности ингибиторов ангиотензинпревращающего фермента в лечении ишемической болезни сердца // Российские медицинские вести.- 2010.- Т. 15 (2).- С. 20-25.
  3. Мареев В. Ю., Агеев Ф. Т., Арутюнов Г. П., Коротеев А. В., Мареев Ю. В., Овчинников А. Г. Беленков Ю. Н., Васюк Ю. А., Галявич А. С., Гарганеева А. А., Гиляревский С. Р., Глезер М. Г., Козиолова Н. А., Коц Я. И., Лопатин Ю. М., Мартынов А. И., Моисеев В. С., Ревишвили А. Ш., Ситникова М. Ю., Скибицкий В. В., Соколов Е. И., Сторожаков Г. И., Фомин И. В., Чесникова А. И., Шляхто Е. В. Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (3 пересмотр) // Сердечная недостаточность. - 2010.- Т. 11 (57).- С. 1-62.
  4. Laura C. Van Vark, Michel Bertrand, K. Martijn Akkerhuis, Jasper J. Brugts, Kim Fox, Jean-Jacques Mourad, Eric Boersma. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of rennin-angiotensin-aldosterone system inhibitors involving 158,998 patients // Eur. Heart. J.- 2012.- Vol. 33.- Р. 2088-2097.
  5. Агеев Ф. Т. Диастолическая сердечная недостаточность: 10 лет знакомства // Сердечная недостаточность.- 2010.- № 11.- С. 5-6.
  6. Zile M. R., Baicu C. F. Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with apreserve dejection fraction // J. Cardiovasc. Transl. Res.- 2013.- Aug; Vol. 6 (4).- Р. 501-515.
  7. Преображенский Д. В., Сидоренко Б. А., Батаралиев Т. А. Ингибиторы ангиотензинпревращающего фермента.- М.: Литтерра, 2007.- 351 с.
  8. Weber K., Brilla C. Pathological hypertrophy and cardiac interstitium. Fibrosis and rennin-angiotensin-aldosterone system // Circulation.- 1991.- Vol. 83.- Р. 1849-1865.
  9. Фомин В. В. Стратегия антигипертензивной терапии при атеросклеротическом поражении сонных артерий: роль ингибиторов ангиотензинпревращающего фермента // Consilium medicum.- 2009.- Т. 11, № 5.- С. 21-26.
  10. Беленков Ю. Н., Привалова Е. В., Данилогорская Ю. А., Железных Е. А., Щендрыгина А. А. Ремоделирование сосудистого русла у больных артериальной гипертонией: возможности диагностики и коррекции // Кардиология.- 2012.- Т. 6.- С. 67-72.
  11. Napoli C. et al. Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension // Am. Heart J.- 2008.- Vol. 156 (6).- Р. 1154-1154.
  12. Автандилов Г. Г. Медицинская морфометрия. Руководство.- М.: Медицина, 1990.- С. 204-205.

Views

Abstract - 26

PDF (Russian) - 0

PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2016 Veber V.R., Rubanova M.P., Zhmailova S.V., Gubskaya P.M., Proshina L.G., Karev V.E., Rumyantsev Y.Y., Ataev I.A., Kulik N.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.